Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 70,557 | 35,659 | 31,701 | 30,077 | 46,642 |
| Operating Income | -69,875 | -35,659 | -31,701 | -30,077 | -46,642 |
| Interest Expense | 13,029 | 10,107 | 9,615 | 9,217 | 9,602 |
| Other Income | 3,334 | 2,523 | 351 | 1,480 | 1,197 |
| Pre-tax Income | -79,570 | -43,243 | -40,965 | -37,814 | -55,047 |
| Net Income Continuous | -79,570 | -43,243 | -40,965 | -37,814 | -55,047 |
| Net Income | $-79,570 | $-43,243 | $-40,965 | $-37,814 | $-55,047 |
| EPS Basic Total Ops | -1.44 | -0.76 | -0.84 | -0.89 | -1.33 |
| EPS Basic Continuous Ops | -1.43 | -0.76 | -0.84 | -0.89 | -1.34 |
| EPS Diluted Total Ops | -1.44 | -0.76 | -0.84 | -0.89 | -1.33 |
| EPS Diluted Continuous Ops | -1.43 | -0.76 | -0.84 | -0.89 | -1.34 |
| EBITDA(a) | $-69,806 | $-34,996 | $-31,305 | $-29,435 | $-45,977 |